Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study. - Agur T; Steinmetz T; Goldman S; Zingerman B; Bielopolski D; Nesher E; Fattal I; Meisel E; Rozen-Zvi B (Kidney medicine, 2026)